Research output per year
Research output per year
Personal profile
Research interests
I conduct clinical trials focused on the treatment and prognosis of patients with leukemias and lymphomas and patients undergoing stem cell transplantation. In addition, my group has established a lymphoma tissue bank for the collection of tumor, blood, bone marrow, and germline tissue from patients with non-Hodgkin and Hodgkin lymphoma. The specimens in the lymphoma tumor bank will be used for the study of clinical, genetic, and immunologic parameters that have prognostic significance and/or are involved in the initiation and progression of lymphoma.
Clinical interests
Oncology, stem cell transplant, CAR T-cell therapy, lymphoma, leukemia, myelodysplastic syndromes.
Fingerprint
Dive into the research topics where Amanda Cashen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies
Desai, P., Lonial, S., Cashen, A., Kamdar, M., Flinn, I., O'Brien, S., Garcia, J. S., Korde, N., Moslehi, J., Wey, M., Cheung, P., Sharma, S., Olabode, D., Chen, H., Syed, F. A., Liu, M., Saeh, J., Andrade-Campos, M., Kadia, T. M. & Blachly, J. S., Nov 1 2024, In: Clinical Cancer Research. 30, 21, p. 4844-4855 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Fehniger, T. A., Watkins, M. P., Ezenwajiaku, N., Wan, F., Hurd, D. D., Cashen, A. F., Blum, K. A., Goy, A., Fenske, T. S., Wagner-Johnston, N. D., Carson, K., Siegel, M. J., Russler-Germain, D., Schneider, S. E., Mehta-Shah, N., Kahl, B. & Bartlett, N. L., Mar 2024, In: Haematologica. 109, 3, p. 953-957 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas
Foley, N., Riedell, P. A., Bartlett, N. L., Cashen, A. F., Kahl, B. S., Fehniger, T. A., Fischer, A., Moreno, C., Liu, J., Carson, K. & Mehta-Shah, N., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article › peer-review
-
Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
Ghobadi, A., Foley, N. C., Cohen, J., Rettig, M. P., Cashen, A. F., Gehrs, L., Christ, S., Street, E., Wallace, N., Ritchey, J., Mehta-Shah, N., Westervelt, P., Fehniger, T. A., Kahl, B., Bartlett, N. L. & DiPersio, J. F., Feb 13 2024, In: Blood Advances. 8, 3, p. 513-522 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation
Foltz, J. A., Tran, J., Wong, P., Fan, C., Schmidt, E., Fisk, B., Becker-Hapak, M., Russler-Germain, D. A., Johnson, J., Marin, N. D., Cubitt, C. C., Pence, P., Rueve, J., Pureti, S., Hwang, K., Gao, F., Zhou, A. Y., Foster, M., Schappe, T. & Marsala, L. & 9 others, , Jun 28 2024, In: Science immunology. 9, 96, eadk4893.Research output: Contribution to journal › Article › peer-review
5 Scopus citations